Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 214 results found. Search for [ cipla ltd ]

Results 1 to 21 of 214
BusinessToday.In
July 3, 2020
Share price of HDFC Life Insurance climbed 5.19% to Rs 576 against previous close of Rs 547.95 on BSE


BusinessToday.In
July 3, 2020
The rupee opened at 74.60 per US dollar, registering a jump of 44 paise over its previous close of 75.01 per dollar on Thursday


BusinessToday.In
July 3, 2020
Stock Market LIVE Updates on July 3: Bajaj Auto, followed by Asian Paints, Bharti Airtel, HUL, Reliance Industries, HUL and Kotak Bank were among the top gainers in the Sensex pack. On the contrary, Tata Steel, HDFC, M&M and Bajaj Finance were among the laggards


BusinessToday.In
July 2, 2020
Share price of Titan Company gained 4.74% or Rs 45 intra day to Rs 993.70 against previous close of Rs 948 on BSE


E Kumar Sharma
July 1, 2020
Avigan, an antiviral drug to fight influenza, is believed to be effective in treatment of COVID-19 patients


Reuters
June 25, 2020
Cipla and Hetero are among a bevy of drugmakers which have licensing agreements with US-based Gilead Sciences Inc, the original manufacturer of remdesivir, to make and sell the drug in 127 low- and middle-income countries


BusinessToday.In
June 24, 2020
RIL stock today touched an intraday high of Rs 1,772, rising 3.02% against the previous close of Rs 1,720 on BSE. The stock opened at Rs 1,739 and also hit an intraday low of Rs 1,712 today


BusinessToday.In
June 24, 2020
Steel Strips Wheels share price gained 19% in one week and 35% in one month, respectively. SSWL stock has given 20% returns to investors in the last 4 days


BusinessToday.In
June 24, 2020
Stock Market LIVE Updates on June 24: HCL Tech, IndusInd Bank, PowerGrid and Infosys were among the laggards. On the other hand, ITC, Bajaj Auto, Bajaj Finance, NTPC and Titan were among the top gainers


Reuters
June 23, 2020
Cipla and privately held Indian drugmaker Hetero Labs on Sunday gained approval to sell generic versions of remdesivir in the country. Hetero expects to price a similar 100 milligram dose of the treatment at 5,000 to 6,000 rupees


BusinessToday.In
June 23, 2020
The government on Tuesday said that it has taken cognizance of the reports in the media about Ayurvedic medicines developed for treatment of coronavirus by Patanjali Ayurved


Reuters
June 23, 2020
Indian drugmakers Hetero Labs and Cipla Ltd on Sunday gained approval to begin selling their generic versions of remdesivir in the country


Rupa Burman Roy
June 22, 2020
Stocks to watch today on June 22: Glenmark Pharma, HDFC, HDFC Bank, Cipla, Bajaj Electricals, Cadila and Dhanlaxmi Bank among others are the top stocks to watch out for in Monday's trading session.


BusinessToday.In
New Delhi, June 21, 2020
These two companies have been approved at a time when coronavirus cases in India are spiralling like never before and putting tremendous pressure on our healthcare system


BusinessToday.In
June 19, 2020
RIL stock rose to all-time high of Rs 1,788.60 on BSE. The stock gained up to 8% or Rs 132 intraday against previous close of Rs 1656.25.


BusinessToday.In
June 19, 2020
Stock Market LIVE Updates on June 19: Bajaj Finserv, Bajaj Finance, ONGC, Tata Steel, JSW Steel were maong the top gainers today. Infosys, HCL Tech, Wipro, Adani Ports, M&M were among the top losers


BusinessToday.In
New Delhi, June 14, 2020
Remdesivir can be administered to patients with moderate disease (those on oxygen), though it should not administered to patients with severe renal impairment, pregnancy or lactating females and children, health ministry guidelines suggest


BusinessToday.In
New Delhi, June 13, 2020
COVID-19 vaccine and drug latest news update: Gilead Sciences Inc had previously signed pacts with five other companies for manufacturing and sale of remdesivir; here are latest updates from across world on coronavirus vaccine developments


BusinessToday.In
May 15, 2020
Cipla's net profit during the March quarter of FY20 took a beating on account of the coronavirus pandemic. The company posted a 33 per cent decline in consolidated net profit during the quarter ended March 2020


Joe C Mathew
New Delhi, May 13, 2020
Under licencing agreements with Gilead Sciences, these companies have a right to receive a technology transfer for Remdesivir to enable them to scale up production more quickly; they can also set their prices for generic product they produce


PAGES 1 OF 11  12345